Dr. Reddy's Laboratories (RDY) said Monday that it has launched its over-the-counter Lanzoprazole delayed release capsules in the U.S market on May 18 after receiving ANDA approval from the United States Food & Drug Administration.
The company will market the capsules under store brand labels in the U.S. Market.
Lanzoprazole delayed release capsule is the bioequivalent version of Novartis Consumer Health's Prevacid 24 HR capsule which received the Rx-to-OTC switch approval with 3 years exclusivity from the FDA on March 18, 2009.
According to SymphonyIRI InfoScan Reviews, this Prevacid capsule market had brand sales of about $115 million for the twelve months ended March 2012.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.